TradingMenu expanded
Forge Markets Browse Companies
DataMenu expanded
Forge Data IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Reports Private Market Data & Analytics Startup News
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Browse Companies
Data Menu expandedData
Forge Data
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Reports
Private Market Data & Analytics
Startup News
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Companies / C4 Therapeutics Stock

C4 Therapeutics Stock

c4therapeutics.comHealthcareFounded: 2016Funding to Date: $74MM

C4 Therapeutics ("C4T") is a biopharmaceutical company focused on harnessing the body’s natural regulation of protein levels to develop novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases.

Learn more about C4 Therapeutics IPO
Register for Details

For more details on financing and valuation for C4 Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for C4 Therapeutics.

Register Today

Team

Management Team

Jane Farran Ph.D
Managing Partner
James Bradner MD
Scientific Co-Founder
Andrew Phillips
Chief Executive Officer
Nathanael Gray Ph.D
Co-Founder & Scientific Advisory Board Member
Chris Nasveschuk Ph.D
Vice President, Chemistry
Marc Cohen
Co-Founder & Executive Chairman
Stewart Fisher Ph.D
Chief Scientific Officer
Isabel Chiu Ph.D
Senior Vice President, Strategic Alliances & Product Management
Adam Crystal
Chief Medical Officer

Board Members

Bruce Downey JD
Elena Prokupets Ph.D
Malcolm Salter
Nathanael Gray Ph.D
Ronald Kaiser
Bihua Chen
Cormorant Asset Management
Ken Anderson MD
Miles Stuchin JD
William Scalzulli
The Kraft Family Foundation
Alain Cohen
Cobro Ventures
Jay Eastman Ph.D
EG Capital Group
Marc Cohen
Norman Gretzinger JD
EG Capital Group

Other companies like C4 Therapeutics in the Healthcare sector

Neuralink
Sector
Healthcare
Last Round Est. Valuation
$2.15B
Colossal Biosciences
Sector
Healthcare
 
 
Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.67B
Synchron
Sector
Healthcare
Last Round Est. Valuation
$400.53MM
Grail
Sector
Healthcare
Last Round Est. Valuation
$4.26B
OURA
Sector
Healthcare
 
 
Cytonics
Sector
Healthcare
 
 
Mammoth Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.08B
Precision Neuroscience
Sector
Healthcare
 
 

News

Business Wire 09/23/2019
C4 Therapeutics Announces the Addition of Ryan B. Corcoran, M.D., Ph.D. to the Scientific Advisory Board
C4 Therapeutics Announces the Addition of Ryan B. Corcoran, M.D., Ph.D. to the Scientific Advisory Board
Fierce Biotech 03/14/2019
C4 poaches new CMO after signing $900M clinical development deal with Roche
C4 Therapeutics has hired Adam Crystal, M.D., Ph.D., a senior director at the Novartis Institutes for BioMedical Research, to be its new chief medical officer and help carry its targeted protein degraders closer to the clinic.

Trending Companies

Frequently Asked Questions